Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Baxter
Medtronic
Fish and Richardson
Mallinckrodt
Covington
US Department of Justice
Fuji
AstraZeneca

Generated: October 17, 2017

DrugPatentWatch Database Preview

ANAPROX DS Drug Profile

« Back to Dashboard

What is the patent landscape for Anaprox Ds, and when can generic versions of Anaprox Ds launch?

Anaprox Ds is a drug marketed by Atnahs Pharma Us and is included in one NDA.

The generic ingredient in ANAPROX DS is naproxen sodium. There are forty-two drug master file entries for this compound. One hundred and sixty-two suppliers are listed for this compound. Additional details are available on the naproxen sodium profile page.

Summary for Tradename: ANAPROX DS

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list53
Clinical Trials: see list4
Patent Applications: see list4,353
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ANAPROX DS at DailyMed

Pharmacology for Tradename: ANAPROX DS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Atnahs Pharma Us
ANAPROX DS
naproxen sodium
TABLET;ORAL018164-003Sep 30, 1987ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ANAPROX DS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Atnahs Pharma Us
ANAPROX DS
naproxen sodium
TABLET;ORAL018164-003Sep 30, 1987► Subscribe► Subscribe
Atnahs Pharma Us
ANAPROX DS
naproxen sodium
TABLET;ORAL018164-003Sep 30, 1987► Subscribe► Subscribe
Atnahs Pharma Us
ANAPROX DS
naproxen sodium
TABLET;ORAL018164-003Sep 30, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
McKesson
Citi
Baxter
Colorcon
AstraZeneca
Argus Health
Farmers Insurance
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot